The global sleep apnea devices market size reached US$ 8.0 Billion in 2023. Looking forward, the publisher expects the market to reach US$ 13.8 Billion by 2032, exhibiting a growth rate (CAGR) of 6.2% during 2023-2032.
Sleep apnea, or sleep-disordered breathing (SDB), is an acute medical condition in which oxygen supply to the brain is obstructed during sleep. It is caused by blockages in the airway resulting in irregular breathing patterns and loud snoring, with the individual often gasping for breath. Sleep apnea diagnostic and therapeutic devices, such as Continuous Positive Airway Pressure (CPAP), Bilevel Positive Airway Pressure (BiPAP) and Variable Positive Airway Pressure (VPAP) machines, are used to evaluate the patient's respiratory and other bodily functions during sleep. Apart from this, numerous oral devices, including the Mandibular Advancement Device (MAD) and tongue retaining device, are also utilized to treat mild to moderate cases of sleep apnea.
The increasing prevalence of obstructive sleep apnea disorder (OSA), central sleep apnea and complex sleep apnea syndrome, are among the key factors driving the growth of the market. Such disorders are highly prevalent among the geriatric population and individuals suffering from other ailments, such as diabetes, hypertension and cardiovascular diseases (CVDs), which is facilitating product adoption across both the developed and emerging nations. Furthermore, product innovations, including Out-of-Center (OOC) testing devices that examine sleep patterns, cardiovascular, oximetry and respiratory parameters for the diagnosis of OSA is also acting as another major growth-inducing factor. Other factors, including improving healthcare infrastructure and growing awareness regarding the prolonged effects of sleep apnea, along with the miniaturization and launch of affordable devices by various brands, are projected to drive the market further.
The increasing prevalence of obstructive sleep apnea disorder (OSA), central sleep apnea and complex sleep apnea syndrome, are among the key factors driving the growth of the market. Such disorders are highly prevalent among the geriatric population and individuals suffering from other ailments, such as diabetes, hypertension and cardiovascular diseases (CVDs), which is facilitating product adoption across both the developed and emerging nations. Furthermore, product innovations, including Out-of-Center (OOC) testing devices that examine sleep patterns, cardiovascular, oximetry and respiratory parameters for the diagnosis of OSA is also acting as another major growth-inducing factor. Other factors, including improving healthcare infrastructure and growing awareness regarding the prolonged effects of sleep apnea, along with the miniaturization and launch of affordable devices by various brands, are projected to drive the market further.
2. What is the expected growth rate of the global sleep apnea devices market during 2024-2032?
3. What has been the impact of COVID-19 on the global sleep apnea devices market?
4. What are the key factors driving the global sleep apnea devices market?
5. What is the breakup of the global sleep apnea devices market based on the product type?
6. What is the breakup of the global sleep apnea devices market based on the end-user?
7. What are the key regions in the global sleep apnea devices market?
8. Who are the key players/companies in the global sleep apnea devices market?
Sleep apnea, or sleep-disordered breathing (SDB), is an acute medical condition in which oxygen supply to the brain is obstructed during sleep. It is caused by blockages in the airway resulting in irregular breathing patterns and loud snoring, with the individual often gasping for breath. Sleep apnea diagnostic and therapeutic devices, such as Continuous Positive Airway Pressure (CPAP), Bilevel Positive Airway Pressure (BiPAP) and Variable Positive Airway Pressure (VPAP) machines, are used to evaluate the patient's respiratory and other bodily functions during sleep. Apart from this, numerous oral devices, including the Mandibular Advancement Device (MAD) and tongue retaining device, are also utilized to treat mild to moderate cases of sleep apnea.
The increasing prevalence of obstructive sleep apnea disorder (OSA), central sleep apnea and complex sleep apnea syndrome, are among the key factors driving the growth of the market. Such disorders are highly prevalent among the geriatric population and individuals suffering from other ailments, such as diabetes, hypertension and cardiovascular diseases (CVDs), which is facilitating product adoption across both the developed and emerging nations. Furthermore, product innovations, including Out-of-Center (OOC) testing devices that examine sleep patterns, cardiovascular, oximetry and respiratory parameters for the diagnosis of OSA is also acting as another major growth-inducing factor. Other factors, including improving healthcare infrastructure and growing awareness regarding the prolonged effects of sleep apnea, along with the miniaturization and launch of affordable devices by various brands, are projected to drive the market further.
The increasing prevalence of obstructive sleep apnea disorder (OSA), central sleep apnea and complex sleep apnea syndrome, are among the key factors driving the growth of the market. Such disorders are highly prevalent among the geriatric population and individuals suffering from other ailments, such as diabetes, hypertension and cardiovascular diseases (CVDs), which is facilitating product adoption across both the developed and emerging nations. Furthermore, product innovations, including Out-of-Center (OOC) testing devices that examine sleep patterns, cardiovascular, oximetry and respiratory parameters for the diagnosis of OSA is also acting as another major growth-inducing factor. Other factors, including improving healthcare infrastructure and growing awareness regarding the prolonged effects of sleep apnea, along with the miniaturization and launch of affordable devices by various brands, are projected to drive the market further.
Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global sleep apnea devices market report, along with forecasts at the global, regional and country level from 2024-2032. The report has categorized the market based on product type and end-user.Breakup by Product Type:
- Therapeutic Devices
- Positive Airway Pressure (PAP) Devices
- Oral Devices
- Nasal Devices
- Chin Straps
- Others
- Diagnostic Devices
- Actigraphs
- Polysomnography Devices
- Sleep Screening Devices
- Others
Breakup by End-User:
- Hospitals and Clinics
- Sleep Laboratories
- Homecare Settings
- Others
Brealup by Region:
- North America
- United States
- Canada
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Chile
- Peru
- Others
- Middle East and Africa
- Turkey
- Saudi Arabia
- Iran
- United Arab Emirates
- Others
Competitive Landscape:
- The competitive landscape of the industry has also been examined with some of the key players being BMC Medical Co., Braebon Medical Corporation, Cadwell Laboratories, CareFusion Corp., Curative Medical, Devilbiss Healthcare, Fisher & Paykel Healthcare, GE Healthcare, Invacare, Oventus Medical, Panthera Dental, ResMed, Somnomed Ltd., Vyaire Medical Inc., Whole You Inc., etc.
Key Questions Answered in This Report
1. What was the size of the global sleep apnea devices market in 2023?2. What is the expected growth rate of the global sleep apnea devices market during 2024-2032?
3. What has been the impact of COVID-19 on the global sleep apnea devices market?
4. What are the key factors driving the global sleep apnea devices market?
5. What is the breakup of the global sleep apnea devices market based on the product type?
6. What is the breakup of the global sleep apnea devices market based on the end-user?
7. What are the key regions in the global sleep apnea devices market?
8. Who are the key players/companies in the global sleep apnea devices market?
Table of Contents
1 Preface3 Executive Summary10 Value Chain Analysis
2 Scope and Methodology
4 Introduction
5 Global Sleep Apnea Devices Market
6 Market Breakup by Product Type
7 Market Breakup by End-User
8 Market Breakup by Region
9 SWOT Analysis
11 Porters Five Forces Analysis
12 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- BMC Medical Co. Braebon Medical Corporation
- Cadwell Laboratories
- CareFusion Corp.
- Curative Medical
- Devilbiss Healthcare
- Fisher & Paykel Healthcare
- GE Healthcare
- Invacare
- Oventus Medical
- Panthera Dental
- ResMed
- Somnomed Ltd.
- Vyaire Medical Inc
- Whole You Inc.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 139 |
| Published | March 2024 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value ( USD | $ 8 Billion |
| Forecasted Market Value ( USD | $ 13.8 Billion |
| Compound Annual Growth Rate | 6.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 14 |
